Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10814503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo *

  1999cited by this paper
• Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries.

  1999cited by this paper
• Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

  1998cited by this paper
• Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis.

  1998cited by this paper
• Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells.

  1998cited by this paper
• Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes.

  1998cited by this paper
• Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

  1998cited by this paper
• Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats.

  1998cited by this paper
• Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.

  1998cited by this paper
• Role of vascular endothelial growth factor in the response to vessel injury.

  1998cited by this paper
• Protein Kinase C δ Inhibits the Proliferation of Vascular Smooth Muscle Cells by Suppressing G1 Cyclin Expression*

  1997cited by this paper
• Angiogenesis in ischemic heart disease

  1997cited by this paper
• Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

  1996cited by this paper
• Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.

  1996cited by this paper
• Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb.

  1996cited by this paper
• Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach.

  1996cited by this paper
• Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells (*)

  1995cited by this paper
• Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells.

  1995cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).

  1994cited by this paper
• Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

  1992cited by this paper

• Cilostazol protects against gastric ulcers by regulating PPAR-γ, HO-1, PECAM-1, pErk-1, NF-κB, Bcl-2, and cleaved caspase-3 protein expression

  2024cites this paper
• 15-Deoxy-Δ-12,14-prostaglandin J2 effects in vascular smooth muscle cells: Implications in vascular smooth muscle cell proliferation and contractility.

  2021cites this paper
• Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation

  2021cites this paper
• 15-Deoxy-Δ12,14-prostaglandin J2 Upregulates VEGF Expression via NRF2 and Heme Oxygenase-1 in Human Breast Cancer Cells

  2021cites this paper
• What is the impact of PPAR-γ agonist-rosiglitazone on ovarian reserve after hysterectomy? An experimental study

  2020cites this paper
• Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor gamma system in experimental rat Barrett's esophagus.

  2020cites this paper
• The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury

  2020cites this paper
• PPARs and Angiogenesis—Implications in Pathology

  2020cites this paper
• Regulation of expression and role of peroxisome proliferator-activated receptors (PPARs) in luminal epithelial and stromal cells of the porcine endometrium.

  2019cites this paper
• Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists

  2019cites this paper
• A novel Ca2+ current blocker promotes angiogenesis and cardiac healing after experimental myocardial infarction in mice

  2018cites this paper
• Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma cruzi-Infected Mice

  2017cites this paper
• Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation

  2017cites this paper
• The Pleiotropic Effects of PPARs on Vascular Cells and Angiogenesis: Implications for Tissue Engineering.

  2016cites this paper
• Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence.

  2016cites this paper
• Microsomal Prostaglandin E Synthase-1 Expression by Aortic Smooth Muscle Cells Attenuates the Differentiated Phenotype

  2016cites this paper
• PPAR Gamma and Angiogenesis: Endothelial Cells Perspective

  2016cites this paper
• Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability

  2015cites this paper
• Human in vivo studies on the non-glycaemic effects of thiazolidinedione derivatives

  2014cites this paper
• Activation of a retinoic acid receptor pathway by thiazolidinediones induces production of vascular endothelial growth factor/vascular permeability factor in OP9 adipocytes.

  2013cites this paper
• Molecular Implications of the PPARs in the Diabetic Eye

  2013cites this paper
• PPAR‐γ – a possible drug target for complicated pregnancies

  2013cites this paper
• Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia

  2013cites this paper
• PPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy

  2012cites this paper
• Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside

  2012cites this paper
• Regulation of ROS Production and Vascular Function by Carbon Monoxide

  2012cites this paper
• The Role of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer

  2012cites this paper
• Acute Rosiglitazone Treatment during Reperfusion after Hyperglycemic Stroke is Neuroprotective Not Vascular Protective

  2012cites this paper
• Rosiglitazone enhances neovascularization in diabetic rat ischemic hindlimb model.

  2012cites this paper
• Pretreatment of Human Mesenchymal Stem Cells with Pioglitazone Improved Efficiency of Cardiomyogenic Transdifferentiation and Cardiac Function

  2011cites this paper
• Rotational co‐culture of clonal β‐cells with endothelial cells: effect of PPAR‐γ agonism in vitro on insulin and VEGF secretion

  2011cites this paper
• Initiation of angiogenesis in atherosclerosis: smooth muscle cells as mediators of the angiogenic response to atheroma formation.

  2011cites this paper
• Tumor Suppressor Pdcd4 Is a Major Transcript That Is Upregulated During In Vivo Pancreatic Islet Neogenesis and Is Expressed in Both Beta-Cell and Ductal Cell Lines

  2011cites this paper
• Early Atheroma-Derived Agonists of Peroxisome Proliferator–Activated Receptor-&ggr; Trigger Intramedial Angiogenesis in a Smooth Muscle Cell–Dependent Manner

  2011cites this paper
• Parallel findings in age-related macular degeneration and Alzheimer's disease.

  2011cites this paper
• PPARs and angiogenesis.

  2011cites this paper
• Intraplaque haemorrhages as the trigger of plaque vulnerability

  2011cites this paper
• Rosiglitazone attenuates hypoxia‐induced pulmonary arterial hypertension in rats

  2010cites this paper
• Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells

  2010cites this paper
• Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes

  2010cites this paper
• Rosiglitazone reverses cardiac adverse remodeling (fibrosis and vascularization) in perinatal low protein rat offspring.

  2010cites this paper
• Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

  2009cites this paper
• Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells.

  2009cites this paper
• Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice.

  2009cites this paper
• Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation

  2009cites this paper
• Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis.

  2009cites this paper
• Reduced Adipose Tissue Oxygenation in Human Obesity

  2009cites this paper
• Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor.

  2009cites this paper
• Targeting the tumor stroma with peroxisome proliferator activated receptor (PPAR) agonists.

  2009cites this paper
• Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes

  2009cites this paper
• Peroxisome proliferator-activated receptors and angiogenesis.

  2009cites this paper
• Herpesvirus Infection Augments the Response to a Subsequent Fibrotic Challenge in the Lung Via the Recruitment of Fibrocytes and the Induction of Pro-fibrotic Factors.

  2009cites this paper
• The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis.

  2008cites this paper
• Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis

  2008cites this paper
• Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?

  2008cites this paper
• Selective Activation of PPAR α and PPAR γ Induces Neoangiogenesis through a VEGF-dependent Mechanism

  2008cites this paper
• Reduced adipose tissue oxygenation in human obesity evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response

  2008cites this paper
• PPARγ and Agonists against Cancer: Rational Design of Complementation Treatments

  2008cites this paper
• Selective Activation of Peroxisome Proliferator–Activated Receptor (PPAR)α and PPARγ Induces Neoangiogenesis Through a Vascular Endothelial Growth Factor–Dependent Mechanism

  2008cites this paper
• The pathogenesis of pterygium: current concepts and their therapeutic implications.

  2008cites this paper
• Impact of diabetes and hypertension on the heart

  2008cites this paper
• Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.

  2008cites this paper
• The Role of PPARs in the Endothelium: Implications for Cancer Therapy

  2008cites this paper
• PPAR-γ, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches

  2008cites this paper
• Thiazolidinediones and their Fluid-Related Adverse Effects

  2007cites this paper
• Cysteinyl Leukotrienes Are Autocrine and Paracrine Regulators of Fibrocyte Function1

  2007cites this paper
• PPAR Action in Human Placental Development and Pregnancy and Its Complications

  2007cites this paper
• Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure.

  2007cites this paper
• PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts.

  2007cites this paper
• Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis

  2007cites this paper
• Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.

  2007cites this paper
• Safety issues and prospects for future generations of PPAR modulators.

  2007cites this paper
• Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant rats.

  2007cites this paper
• Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition.

  2006cites this paper
• Upregulation of VEGF by 15‐Deoxy‐Δ12,14‐Prostaglandin J2 via Heme Oxygenase‐1 and ERK1/2 Signaling in MCF‐7 Cells

  2006cites this paper
• Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells.

  2006cites this paper
• PPAR$$\upgamma$$ represses VEGF expression in human endometrial cells: Implications for uterine angiogenesis

  2006cites this paper
• Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression

  2006cites this paper
• Adipose‐specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARγ agonist's effects on edema and weight gain

  2006cites this paper
• Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia.

  2006cites this paper
• Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1.

  2006cites this paper
• Placental Expression of Peroxisome Proliferator-Activated Receptors in Rat Pregnancy and the Effect of Increased Glucocorticoid Exposure1

  2006cites this paper
• Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.

  2006cites this paper
• Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation : novel mechanism for PPAR agonist ’ s effects on edema and weight gain

  2006cites this paper
• Effects of luteinizing hormone on peroxisome proliferator-activated receptor gamma in the rat ovary before and after the gonadotropin surge.

  2006cites this paper
• The potential of antidiabetic thiazolidinediones for anticancer therapy

  2006cites this paper
• Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat.

  2006cites this paper
• Modulation of peroxisome proliferator-activated receptor delta and gamma transcripts in swine endometrial tissue during early gestation.

  2006cites this paper
• Agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ: A new compound with potent gastroprotective and ulcer healing properties

  2005cites this paper
• Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.

  2005cites this paper
• Effects of Embryo Culture on Angiogenesis and Morphometry of Bovine Placentas During Early Gestation1

  2005cites this paper
• Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet.

  2005cites this paper
• Hyperhomocysteinemia exacerbates the development of intimal hyperplasia in Sprague-Dawley rats: Alleviation by rosiglitazone.

  2005cites this paper
• Peroxisome proliferator-activated receptors and their relevance to dermatology.

  2005cites this paper
• Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?

  2005cites this paper
• PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats.

  2005cites this paper
• New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARgamma agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapy.

  2005cites this paper
• Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.

  2005cites this paper
• COX and PPAR: Possible Interactions in Pancreatic Cancer

  2004cites this paper
• Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione.

  2004cites this paper